Autopsy report · NCT00785772

A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment

“See termination reason in detailed description.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 4 months before it started.
• Ran for about 1 month before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 1 year after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Sponsor type

Industry

Conditions

Renal Impairment

Interventions

Gabapentin; Gabapentin; Gabapentin

Participants

1

Sites

1

Countries

Japan

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.